Tailoring insulin 
therapy for improved 
patient outcomes

28TH MAY
SATURDAY
8:30AM - 1:00PM
UAE TIME (GMT+4)
REGISTER

WELCOME MESSAGE


Welcome to INSTALL regional

Diabetes is one of the leading modifiable causes of fatality worldwide. The condition is associated with a defect in either production or utilization of the hormone insulin, thus, making therapy with insulin an integral part of diabetes management. Over the decades, insulin therapy has undergone extensive transformations which have estabilished its’ distinguised position in current management practices. In recent years, insulin has made some noteworthy leaps towards enhanced patient outcomes.


The INSTALL regional workshop will cover the following objectives :







  1. Emphasize the significance of timely insulin intervention in patients with type 2 diabetes.
  2. Understand and overcome hurdles related to initiation and titration in patients with type 2 diabetes.
  3. Appreciate the role of insulin degludec in improving glycemic control in patients with type 2 diabetes.
  4. Engage in a vast range of interactive activities to fully grasp the concept of insulin optimization for improved outcomes in patients with diabetes.

We look forward to your presence and active participation during the workshop.

Sincerely,

Prof. Mohamed Hassanein

Consultant in Diabetes & Endocrinology, Dubai Hospital,
UAE H Professor of Medicine, Gulf Medical University
A Professor of Medicine, Mohamed Bin-Rashid University, UAE
Associate Director, Post Graduate Diabetes Education, Cardiff University. UK
Chair of DAR International Alliance

Diabetes is one of the leading modifiable causes of fatality worldwide. The condition is associated with a defect in either production or utilization of the hormone insulin, thus, making therapy with insulin an integral part of diabetes management.
Over the decades, insulin therapy has undergone extensive transformations which have estabilished its’ distinguised position in current management practices.
In recent years, insulin has made some noteworthy leaps towards enhanced patient outcomes.

  1. Emphasize the significance of timely insulin intervention in patients with type 2 diabetes.
  2. Understand and overcome hurdles related to initiation and titration in patients with type 2 diabetes.
  3. Appreciate the role of insulin degludec in improving glycemic control in patients with type 2 diabetes.
  4. Engage in a vast range of interactive activities to fully grasp the concept of insulin optimization for improved outcomes in patients with diabetes.

We look forward to your presence and active participation during the workshop.

Sincerely,

Prof. Mohamed Hassanein

Consultant in Endocrinology, Dubai Hospital
H. Senior Lecturer, Cardiff University, UK
Chair Diabetes and Ramadan (DAR) International Alliance

REGISTER